U.S. flag

An official website of the United States government

NM_000500.9(CYP21A2):c.1451G>A (p.Arg484Gln) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Aug 25, 2015
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000711373.4

Allele description [Variation Report for NM_000500.9(CYP21A2):c.1451G>A (p.Arg484Gln)]

NM_000500.9(CYP21A2):c.1451G>A (p.Arg484Gln)

Genes:
LOC106780800:CYP21A2 recombination region [Gene]
CYP21A2:cytochrome P450 family 21 subfamily A member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.33
Genomic location:
Preferred name:
NM_000500.9(CYP21A2):c.1451G>A (p.Arg484Gln)
HGVS:
  • NC_000006.12:g.32041097G>A
  • NG_007941.3:g.7793G>A
  • NG_008337.2:g.73278C>T
  • NG_045215.1:g.3326G>A
  • NM_000500.9:c.1451G>AMANE SELECT
  • NM_001128590.4:c.1361G>A
  • NM_001368143.2:c.1046G>A
  • NM_001368144.2:c.1046G>A
  • NP_000491.4:p.Arg484Gln
  • NP_001122062.3:p.Arg454Gln
  • NP_001355072.1:p.Arg349Gln
  • NP_001355073.1:p.Arg349Gln
  • LRG_829t1:c.1451G>A
  • LRG_829:g.7793G>A
  • LRG_829p1:p.Arg484Gln
  • NC_000006.11:g.32008874G>A
  • NM_000500.7:c.1451G>A
Protein change:
R349Q
Links:
dbSNP: rs200005406
NCBI 1000 Genomes Browser:
rs200005406
Molecular consequence:
  • NM_000500.9:c.1451G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128590.4:c.1361G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368143.2:c.1046G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368144.2:c.1046G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000841736Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Pathogenic
(Aug 25, 2015)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV004221766Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Pathogenic
(Aug 25, 2015)
unknownclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.

Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, Guan Q, Zhou X, Zheng D, Li G, Zhao J.

Mol Genet Genomic Med. 2019 Jun;7(6):e671. doi: 10.1002/mgg3.671. Epub 2019 Apr 9.

PubMed [citation]
PMID:
30968594
PMCID:
PMC6565591

Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.

Fernández CS, Taboas M, Bruque CD, Benavides-Mori B, Belli S, Stivel M, Oneto A, Pasqualini T, Delea M, Espeche LD, Kolomenski JE, Alba L, Buzzalino N, Dain L.

Clin Endocrinol (Oxf). 2020 Jul;93(1):19-27. doi: 10.1111/cen.14190. Epub 2020 May 3.

PubMed [citation]
PMID:
32289882
See all PubMed Citations (11)

Details of each submission

From Athena Diagnostics, SCV000841736.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV004221766.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

The CYP21A2 c.1451G>A (p.Arg484Gln) variant (also known as R484Q and R483Q) has been reported in the published literature in several individuals affected with 21 hydroxylase deficiency (PMIDs: 33864926 (2021), 30048636 (2018), 24667412 (2014), 24790362 (2008)) with either a simple virilizing (PMIDs: 32289882 (2020), 17119906 (2007)) or a nonclassic (PMIDs: 30968594 (2019), 19208730 (2009), 12915679 (2003)) phenotype. Functional studies show the variant has severely reduced activity, 1.1-1.89% activity for17-OHP and 2-3.8% activity for progesterone, compared to the wild-type (PMIDs: 24790362 (2008), 17119906 (2007)). The frequency of this variant in the general population, 0.0000088 (2/227246 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Based on the available information, this variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024